Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data

References

• Giannakoulis VG, Papoutsi E, Siempos II. Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data. J Cin Oncol Glob Oncol. 2020;6(6):799–808.
   PubMedGoogle Scholar
• Richards M, Anderson M, Carter P, et al. The impact of the COVID-19 pandemic on cancer care. Nat Cancer. 2020;1(6):565–567.
   PubMedGoogle Scholar
• Balogun OD, Bea VJ, Phillips E. Disparities in cancer outcomes due to COVID-19 – a tale of 2 cities. JAMA Oncol. 2020;6(10):1531.
   PubMed Web of Science ®Google Scholar
• Sharpless NE. COVID-19 and cancer. Science. 2020;368(6497):1290–1290.
   PubMed Web of Science ®Google Scholar
• Russell B, Moss C, George G, et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022. DOI:10.3332/ecancer.2020.1022
   Google Scholar
• Segelov E, Prenen H, Day D, ASCOLT Investigators, et al. Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial. JCO Glob Oncol. 2020;6:585–588.
   PubMedGoogle Scholar
• Kumar D, Dey T. Treatment delays in oncology patients during COVID-19 pandemic: a perspective. J Glob Health. 2020;10(1):010367.
   PubMed Web of Science ®Google Scholar
• Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337.
   PubMed Web of Science ®Google Scholar
• Robilotti EV, Babady NE, Mead PA, et al. Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020;26:1218–1223.
   Google Scholar
• Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894–901.
   PubMed Web of Science ®Google Scholar
• Vuagnat P, Frelaut M, Ramtohul T, Institut Curie Breast Cancer and COVID Group, et al. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area. Breast Cancer Res. 2020;22(1):55.
   PubMed Web of Science ®Google Scholar
• Basse C, Diakite S, Servois V, et al. Characteristics and outcome of SARS-CoV-2 infection in cancer patients. JNCI Cancer Spectr. 2020;pkaa090. DOI:10.1093/jncics/pkaa090
   Web of Science ®Google Scholar
• Russell B, Moss C, Papa S, et al. Factors affecting COVID-19 outcomes in cancer patients – a first report from Guy's Cancer Centre in London. Front Oncol. 2020;10:1279.
   PubMed Web of Science ®Google Scholar
• Jee J, Foote MB, Lumish M, et al. Chemotherapy and COVID-19 outcomes in patients with cancer. J Clin Oncol. 2020;38(30):3538–3546.
   PubMed Web of Science ®Google Scholar
• Pinato DJ, Zambelli A, Aguilar-Company J, et al. Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. Cancer Discov. 2020;10(10):1465–1474.
   PubMed Web of Science ®Google Scholar
• Luo J, Rizvi H, Egger JV, et al. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers. Cancer Discov. 2020;10(8):1121–1128.
   PubMed Web of Science ®Google Scholar
• Tian J, Yuan X, Xiao J, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):893–903. in press.
   PubMed Web of Science ®Google Scholar
• Brar G, Pinheiro LC, Shusterman M, et al. COVID-19 severity and outcomes in patients with cancer: a matched cohort study. J Clin Oncol. 2020. DOI:10.1200/JCO.20.01580
   PubMed Web of Science ®Google Scholar
• Stroppa EM, Toscani I, Citterio C, et al. Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy). Future Oncol. 2020;16(20):1425–1432.
   PubMed Web of Science ®Google Scholar
• Vento S, Cainelli F, Temesgen Z. Lung infections after cancer chemotherapy. Lancet Oncol. 2008;9(10):982–992.
   PubMed Web of Science ®Google Scholar
• Nepogodiev D, Bhangu A, Glasbey JC, et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020;396(10243):27–38.
   PubMed Web of Science ®Google Scholar
• Schmidt FL, Oh IS, Hayes TL. Fixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results. Br J Math Stat Psychol. 2009;62(Pt 1):97–128.
   Google Scholar
• Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–1918.
   PubMed Web of Science ®Google Scholar
• Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904–913.
   PubMed Web of Science ®Google Scholar
• Garassino MC, Whisenant JG, Huang L-C, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21(7):914–922.
   PubMed Web of Science ®Google Scholar
• Wang J, Song Q, Chen Y, et al. Systematic investigations of COVID-19 in 283 cancer patients. medRxiv. 2020. DOI:10.1101/2020.04.28.20083246
   Google Scholar
• Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926.
   PubMed Web of Science ®Google Scholar
• Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783–791.
   PubMed Web of Science ®Google Scholar
• Yu J, Ouyang W, Chua MLK, et al. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020;6(7):1108–1110.
   PubMed Web of Science ®Google Scholar
• Luo J, Rizvi H, Preeshagul IR, et al. COVID-19 in patients with lung cancer. Ann Oncol. 2020;31(10):1386–1396.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Cao M, Antonazas-Basa M, Puertolas T, et al. Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients. medRxiv. 2020;2020:05–19. 20106971.
   Google Scholar
• Zhang H, Wang L, Chen Y, et al. Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China. Cancer. 2020;126(17):4023–4031.
   PubMed Web of Science ®Google Scholar
• Mehta V, Goel S, Kabarriti R, et al. Case fatality rate of cancer patients with COVID-19 in a New York Hospital System. Cancer Discov. 2020;10(7):935–941.
   PubMed Web of Science ®Google Scholar
• Bogani G, Ditto A, Bosio S, et al. Cancer patients affected by COVID-19: experience from Milan, Lombardy. Gynecol Oncol. 2020;158(2):262–265. in press.
   PubMed Web of Science ®Google Scholar
• de Melo AC, Thuler LCS, da Silva JL, et al. Cancer inpatient with COVID-19: a report from the Brazilian National Cancer Institute. medRxiv. 2020. DOI:10.1101/2020.06.27.20141499
   Google Scholar
• Angelis V, Tippu Z, Joshi K, et al. Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer. Eur J Cancer. 2020;136:99–106.
   PubMed Web of Science ®Google Scholar
• Yarza R, Bover M, Paredes D, et al. SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death. Eur J Cancer. 2020;135:242–250.
   PubMed Web of Science ®Google Scholar
• Albiges L, Foulon S, Bayle A, et al. Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort. Nat Cancer. 2020;1:965–975.
   PubMedGoogle Scholar